Deal Announcements

Cervilenz Sees Series A Venture Capital Financing

Thursday, May 14, 2009 5:38:00 AM PDT | VentureDeal Staff

Chagrin Falls, Ohio  --  Medical device company Cervilenz has secured $4 million in its first round of institutional venture capital financing.

Cervilenz has developed an FDA cleared device that predicts preterm birth risk by accurately measuring cervical length in pregnant women.

Arboretum Ventures led the round, which also included Chrysalis Ventures. The company did not disclose how the funding procedure could be used.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1